PG
GILD icon

Portola Group’s Gilead Sciences GILD Stock Holding History

Portola Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$439K Buy
3,750
+1,350
+56% +$148K 0.58% 51
2015
Q1 		$236K Sell
2,400
-200
-8% -$20.3K 0.29% 63
2014
Q4 		$245K Buy
+2,600
New +$269K 0.27% 70
2013
Q4 		– Sell
-31,350
Closed -$1.97M – 91
2013
Q3 		$1.97M Buy
+31,350
New +$1.87M 1.2% 26

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Portola Group's GILD Position: Q2 2015 in Review

Portola Group increased its Gilead Sciences (GILD) stake by 56% in Q2 2015, buying an estimated $148K and bringing the position to 3,750 shares worth $439K. The position accounts for 0.58% of the portfolio, ranked #51.

Portola Group first reported a position in GILD in Q3 2013 and has held it in 4 quarters since. The position peaked at $1.97M in Q3 2013. 1,560 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Portola Group held 3,750 shares of Gilead Sciences worth $439K as of Q2 2015.
  • Portola Group bought 1,350 Gilead Sciences shares in Q2 2015, an estimated $148K.
  • Gilead Sciences made up 0.58% of Portola Group's portfolio in Q2 2015, its #51 holding.
  • Portola Group first reported a position in Gilead Sciences in Q3 2013 and has held it in 4 quarters since.
  • Portola Group's Gilead Sciences position peaked at $1.97M in Q3 2013.
  • 1,560 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Portola Group's 13F filing for Q2 2015, filed 17 Jul 2015.